PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation
LAS VEGAS, NV, November 12, 2021 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that the empty capsule material that makes up its CypCaps™ pancreatic cancer product does not cause skin irritation. PharmaCyte’s Chief
Read more →